Aguettant Diagnostics, incorporated on 1st July 2022, is the diagnostic entity of Aguettant Group. Based in Lyon, on the same site as its parent company, Aguettant Diagnostics offers 2000m² of infrastructures dedicated to the development, the industrialization and the production of Elisa tests and rapid lateral flow tests.
This diagnostic entity has been created in continuity with the development of the medtech Promise Proteomics which propose innovative solutions for the quantification of biotherapies and subsidiary of Aguettant Group.
Company Details
- Employees
- 6
- Address
- 2, Rue Alexander Fleming, Lyon,auvergne-Rhône-Alpes 69007,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Lyon, Auvergne-Rhône-Alpes
Aguettant Diagnostics Questions
Aguettant Diagnostics's LinkedIn profile is https://fr.linkedin.com/company/aguettant-diagnostics
Aguettant Diagnostics has
6 employees.
View email and phone details for 6
employees at Aguettant Diagnostics.
Aguettant Diagnostics's industry is
Biotechnology Research
Aguettant Diagnostics's top competitors are
Cytoo,
Synthelis,
Biotem First Class Antibodies & Immunoassays,
Lyonbiopôle Auvergne-Rhône-Alpes,
Laboratoire Aguettant,
Adocia,
Magia Diagnostics,
Promise Proteomics,
Iq Proteomics,
Biosellal.
Aguettant Diagnostics's categories are Biotechnology Research
